Martin Kesselgruber, VP Head of Global Project Management at Bachem, offers insights on the key measures for companies to ...

Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment ...

More data leads to more precise answers, and the biopharma industry has at its disposal more data than ever before.

We are excited to welcome the talented team at Regulus to Novartis as we continue to build on our pipeline in renal disease with high unmet medical need.” Farabursen is an investigational ...

U.S. exchange operators are in talks with the Securities and Exchanges Commission on easing regulatory burdens for public ...

The designation reinforces the potential of QRX003 as a therapeutic candidate for a profoundly underserved pediatric population. It follows earlier regulatory recognition by the European Medicines ...

The Trump administration aims to issue a rule empowering regulators to “forcefully” go after companies that don’t share drug ...

BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) has announced an updated timeline for submitting its Biologics ...

Speaking at BIO2025, rare disease leaders from Ultragenyx, Amylyx and Yale questioned the need for the new regulatory pathway ...

The International Health Regulations 2005 (IHR) is a legally binding framework which requires 196 WHO Member States to take actions to prevent, protect against, control and provide public health ...

Legal Regulatory Requirements on the Human Resource Process. Human resources management must comply with all employment, health and safety and other relevant legislation applicable to the ...